辛夷脂素抑制劑1. Fargesin as a potential β1AR antagonist through cAMP/PKA pathway could protect against myocardial ischemia/reperfusion injury in rats. 2. Fargesin improves dyslipidemia and hyperglycemia by activating Akt and AMPK in WAT.
| 產品名稱： | 辛夷脂素 | ||
| 英文名： | Fargesin | ||
| CAS NO.： | 31008-19-2 | ||
| 分子式： | C21H22O6 | ||
| 分子量： | 370.395786762238 | ||
| 產品品牌： | targetmol | ||
| 產品規格： | 1mg | ||
